ES2166021T3 - Procedimiento para la preparacion de 4-aril-3-hidroximetilpiperidinas. - Google Patents

Procedimiento para la preparacion de 4-aril-3-hidroximetilpiperidinas.

Info

Publication number
ES2166021T3
ES2166021T3 ES97106096T ES97106096T ES2166021T3 ES 2166021 T3 ES2166021 T3 ES 2166021T3 ES 97106096 T ES97106096 T ES 97106096T ES 97106096 T ES97106096 T ES 97106096T ES 2166021 T3 ES2166021 T3 ES 2166021T3
Authority
ES
Spain
Prior art keywords
group
hydrogen atom
hydroximethylpiperidins
aril
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97106096T
Other languages
English (en)
Inventor
Shu-Zhong Wang
Takashi Okazoe
Yasushi Matsumura
Nobuaki Mori
Jiro Nishino
Kazuhiro Ookura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Application granted granted Critical
Publication of ES2166021T3 publication Critical patent/ES2166021T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Abstract

UN PROCEDIMIENTO DE PRODUCCION DE UN PIPERIDINCARBINOL REPRESENTADO POR LA FORMULA GENERAL (2) QUE CONSISTE EN REDUCIR EL ISOMERO TRANS DE UN COMPUESTO REPRESENTADO POR LA FORMULA GENERAL (1): DONDE R{SUP,1} ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR O UN GRUPO ARALQUILO, R{SUP,2} ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR, UN GRUPO ARILO O UN GRUPO ARALQUILO, Y X ES UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO, UN GRUPO ALQUILO, ARILO, ARALQUILO, ALCOXI, DIALQUILAMINO, ALQUILTIO, ARILTIO O C{SUB,M}F{SUB,2M+1 }, DONDE M ES UN ENTERO COMPRENDIDO ENTRE 1 Y 20.
ES97106096T 1996-04-15 1997-04-14 Procedimiento para la preparacion de 4-aril-3-hidroximetilpiperidinas. Expired - Lifetime ES2166021T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09279196A JP3446468B2 (ja) 1996-04-15 1996-04-15 ピペリジンカルビノール類の製造方法

Publications (1)

Publication Number Publication Date
ES2166021T3 true ES2166021T3 (es) 2002-04-01

Family

ID=14064248

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97106096T Expired - Lifetime ES2166021T3 (es) 1996-04-15 1997-04-14 Procedimiento para la preparacion de 4-aril-3-hidroximetilpiperidinas.

Country Status (9)

Country Link
US (3) US6197960B1 (es)
EP (1) EP0802185B1 (es)
JP (1) JP3446468B2 (es)
AT (1) ATE207055T1 (es)
CA (1) CA2202577C (es)
DE (1) DE69707341T2 (es)
DK (1) DK0802185T3 (es)
ES (1) ES2166021T3 (es)
PT (1) PT802185E (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0812827B1 (en) 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
JP2002514222A (ja) * 1997-05-29 2002-05-14 スミスクライン・ビーチャム・コーポレイション 新規方法
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
ES2137131B1 (es) * 1998-02-06 2000-09-16 Vita Invest Sa Derivado de piperidinona procedimiento de obtencion y procedimiento para su utilizacion.
ES2149687B1 (es) * 1998-04-08 2001-05-16 Medichem Sa Procedimiento de obtencion de (+-)-trans-4-(4-fluorofenil)-3-hidroximetilpiperidinas e intermedios de sintesis para las mismas.
DE69910691T2 (de) 1998-06-29 2004-07-08 Sumika Fine Chemical Co. Ltd. L-Tartrate von Trans-(-)-4-(4-Fluorphenyl)-3-Hydroxymethyl-Piperidin Verbindungen und Verfahren zu ihrer Herstellung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
AU6360999A (en) * 1998-11-02 2000-05-22 Synthon B.V. Process for producing 4-arylpiperidine-3-carbinols and related compounds
EP1140832A4 (en) * 1998-12-22 2004-11-03 Pentech Pharmaceuticals Inc PROCESS FOR THE PREPARATION OF INTERMEDIATES AND DERIVATIVES OF ARYLPIPERIDINE CARBINOL
GB9915727D0 (en) * 1999-07-03 1999-09-08 Smithkline Beecham Plc Novel compound and process
EP1280775A1 (en) 2000-05-12 2003-02-05 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
CA2464327A1 (en) 2001-10-22 2003-05-30 Synthon B.V. N-formyl derivatives of paroxetine
EP1954329B1 (en) * 2005-12-01 2016-03-09 SCA Hygiene Products AB New absorbent article
WO2015071831A1 (en) * 2013-11-18 2015-05-21 Piramal Enterprises Limited An improved process for minimising the formation of dehalogenated byproducts
CN115108968A (zh) * 2021-03-23 2022-09-27 上药康丽（常州）药业有限公司 一种3-(4-溴苯基)-哌啶的生产方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
CH636858A5 (de) * 1977-01-17 1983-06-30 Ciba Geigy Ag Verfahren zur herstellung neuer phenylazacycloalkane.
US4593036A (en) 1984-02-07 1986-06-03 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
DE3680184D1 (de) 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
GB8520154D0 (en) 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
US5227379A (en) 1986-11-03 1993-07-13 Novo Nordisk A/S Piperidine compounds and their preparation and use
IE66332B1 (en) 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
DK716088D0 (da) 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
US5258517A (en) 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
JPH0696551A (ja) 1992-09-11 1994-04-08 Kao Corp 磁気ディスクカートリッジ
GB9305175D0 (en) 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
EP0812827B1 (en) 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
US5672612A (en) 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition

Also Published As

Publication number Publication date
DE69707341D1 (de) 2001-11-22
PT802185E (pt) 2002-01-30
US6590102B1 (en) 2003-07-08
JP3446468B2 (ja) 2003-09-16
JPH09278754A (ja) 1997-10-28
EP0802185B1 (en) 2001-10-17
US6476228B1 (en) 2002-11-05
CA2202577A1 (en) 1997-10-15
CA2202577C (en) 2006-05-30
DE69707341T2 (de) 2002-07-25
EP0802185A1 (en) 1997-10-22
ATE207055T1 (de) 2001-11-15
US6197960B1 (en) 2001-03-06
DK0802185T3 (da) 2001-11-19

Similar Documents

Publication Publication Date Title
ES2166021T3 (es) Procedimiento para la preparacion de 4-aril-3-hidroximetilpiperidinas.
DK1254883T3 (da) Fremgangsmåde til fremstilling af substitueret 1,1,1-trifluoro-3-butene-2-oner
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE69529619D1 (en) Pyrimidinylpyrazolderivate
FI913067A0 (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
ES2064557T3 (es) Derivados de 1-fenilalquil-3-fenilurea.
ES2144327T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
DK0455899T3 (da) Prostaglandin I-analog
ATE90101T1 (de) Verfahren zur herstellung von makrolid-derivaten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 802185

Country of ref document: ES